406 related articles for article (PubMed ID: 19450513)
21. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action.
Takashima M; Ogawa W; Hayashi K; Inoue H; Kinoshita S; Okamoto Y; Sakaue H; Wataoka Y; Emi A; Senga Y; Matsuki Y; Watanabe E; Hiramatsu R; Kasuga M
Diabetes; 2010 Jul; 59(7):1608-15. PubMed ID: 20393151
[TBL] [Abstract][Full Text] [Related]
22. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
Sajan MP; Ivey RA; Lee MC; Farese RV
J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
[TBL] [Abstract][Full Text] [Related]
23. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2.
Dentin R; Liu Y; Koo SH; Hedrick S; Vargas T; Heredia J; Yates J; Montminy M
Nature; 2007 Sep; 449(7160):366-9. PubMed ID: 17805301
[TBL] [Abstract][Full Text] [Related]
24. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.
Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J
Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456
[No Abstract] [Full Text] [Related]
25. Dapagliflozin attenuates renal gluconeogenic enzyme expression in obese rats.
Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
J Endocrinol; 2020 May; 245(2):193-205. PubMed ID: 32092034
[TBL] [Abstract][Full Text] [Related]
26. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.
Miller RA; Chu Q; Xie J; Foretz M; Viollet B; Birnbaum MJ
Nature; 2013 Feb; 494(7436):256-60. PubMed ID: 23292513
[TBL] [Abstract][Full Text] [Related]
27. Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation.
Hussain MA; Porras DL; Rowe MH; West JR; Song WJ; Schreiber WE; Wondisford FE
Mol Cell Biol; 2006 Oct; 26(20):7747-59. PubMed ID: 16908541
[TBL] [Abstract][Full Text] [Related]
28. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
29. Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms.
Cleasby ME; Dzamko N; Hegarty BD; Cooney GJ; Kraegen EW; Ye JM
Diabetes; 2004 Dec; 53(12):3258-66. PubMed ID: 15561958
[TBL] [Abstract][Full Text] [Related]
30. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.
Koo SH; Flechner L; Qi L; Zhang X; Screaton RA; Jeffries S; Hedrick S; Xu W; Boussouar F; Brindle P; Takemori H; Montminy M
Nature; 2005 Oct; 437(7062):1109-11. PubMed ID: 16148943
[TBL] [Abstract][Full Text] [Related]
31. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
32. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling.
Canettieri G; Koo SH; Berdeaux R; Heredia J; Hedrick S; Zhang X; Montminy M
Cell Metab; 2005 Nov; 2(5):331-8. PubMed ID: 16271533
[TBL] [Abstract][Full Text] [Related]
33. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
Lee JM; Han HS; Jung YS; Harris RA; Koo SH; Choi HS
J Biol Chem; 2018 Aug; 293(34):13125-13133. PubMed ID: 29950523
[TBL] [Abstract][Full Text] [Related]
34. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans.
Banerjee J; Bruckbauer A; Zemel MB
Metabolism; 2016 Nov; 65(11):1679-1691. PubMed ID: 27456392
[TBL] [Abstract][Full Text] [Related]
35. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
36. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
37. B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB.
Hwang SL; Kwon O; Lee SJ; Roh SS; Kim YD; Choi JH
Biochem Biophys Res Commun; 2012 Nov; 427(4):801-5. PubMed ID: 23058912
[TBL] [Abstract][Full Text] [Related]
38. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
Mitchell PL; Nachbar R; Lachance D; St-Pierre P; Trottier J; Barbier O; Marette A
Diabetes Obes Metab; 2017 Mar; 19(3):313-319. PubMed ID: 27800648
[TBL] [Abstract][Full Text] [Related]
39. More TORC for the gluconeogenic engine.
Cheng A; Saltiel AR
Bioessays; 2006 Mar; 28(3):231-4. PubMed ID: 16479585
[TBL] [Abstract][Full Text] [Related]
40. Metabolic Effects of Metformin in Humans.
Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
